Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Telomere length may reflect disease progression in AIDS patients

July 5, 1996

RiboGene licenses anti-HIV compounds from Warner-Lambert

July 5, 1996

Vistide approved in U.S.

July 5, 1996

Various research groups announce independent discovery of receptor for HIV infection

July 5, 1996

CryptoGam demonstrates clear antimicrobial effect in clinical trial

July 5, 1996

Synovir clinical program expanded

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

CPMP approves saquinavir for marketing

July 5, 1996

HIV protease inhibitors reported by Pharmacia & Upjohn

July 5, 1996

Glaxo Wellcome, Vertex license anti-HIV patents from Searle

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...